Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Joel M. Gelfand, MD, MSCE

Joel M. Gelfand, MD, MSCE Physician

Director, Psoriasis and Phototherapy Treatment Center
Vice Chair of Clinical Research and Medical Director, Dermatology Clinical Studies Unit
Professor of Dermatology
Professor of Epidemiology in Biostatistics and Epidemiology

Dr. Gelfand is a Penn Medicine employed physician.

About Dr. Joel M. Gelfand

Recognized by Best Doctors in America 2007-2008, 2009-2010, 2011-2012

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties

Specialty:

  • Dermatology

Programs & Centers:

Board Certification:

  • Dermatology, 2002

Clinical Expertise:

  • Age Spot Removal
  • Basal Cell Carcinoma
  • Cellulitis
  • Contact Dermatitis (Contact Eczema)
  • Cutaneous T-Cell Lymphoma
  • Dermatitis Herpetiformis (Duhring's Disease)
  • Dermato Cellulitis
  • Dermatomyositis
  • Dysplastic Nevi (Atypical Moles)
  • Eczema (Atopic Dermatitis)
  • Epidemiology - Hospital
  • Excessive Body Hair
  • Facial Lesions
  • Facial Skin Lesion Removal
  • Fungal Skin Infections (Dermatomycosis)
  • Genetic Skin Disorders
  • Genital Warts (Condyloma Acuminatum)
  • Hair Loss (Alopecia Areata)
  • Herpes Simplex Virus (HSV)
  • Hidradenitis (Sweat Glands Disease)
  • Hirsutism
  • Immunodermatology
  • Melanoma
  • Mole Check
  • Mole Removal
  • Occupational Dermatitis
  • Pigmented Lesion Removal
  • Psoriatic Arthritis
  • Pyoderma Gangrenosum
  • Radiation Dermatitis
  • Removal of Skin Growths
  • Sclerotherapy for Varicose and Spider Veins
  • Seborrheic Dermatitis (Seborrheic Eczema)
  • Second Opinion
  • Skin Allergies
  • Skin Cancer
  • Skin Check
  • Skin Lesion Biopsy
  • Skin Lesion Removal
  • Skin Phototesting
  • Skin Problems in Ethnic Groups
  • Skin Tags Removal

Practice Locations and Appointments

  • Penn Dermatology

    Perelman Center for Advanced Medicine South Pavilion, 1st Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-PENN (7366)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Harvard Medical School
Residency: Mount Sinai Hospital
Residency: Hospital of the University of Pennsylvania
Fellowship: Hospital of the University of Pennsylvania
Medical School: University of Pennsylvania School of Medicine

Memberships

Advisory Committee Boston University's NIAMS Multidisciplinary Clinical Research Center (P60), National American Academy of Dermatology, National American Board of Dermatology, National American Dermatological Association, National American Society for Clinical Investigation, National American Society for Dermatoepidemiology, National Cancer Center, University of Pennsylvania, Local Data Safety monitoring board Coherus Biosciences, National Data Safety Monitoring Board, Merck, Phase III Psoriasis Program, International Dermatology Foundation, National Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, International Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, International Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Local International Psoriasis Council, International International Society for Pharmacoepidemiology, International Massachusetts Medical Society, National Medical Dermatology Society, National National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), National National Multiple Sclerosis Society Serially Unified Multicenter Multiple Sclerosis Investigation (SUMMIT), National National Psoriasis Foundation, National Penn Center for Orphan Disease Research and Therapy, National PENN Institute for Immunology, Local Pennsylvania Academy of Dermatology and Dermatologic Surgery, Local Scientific Advisory Committee (Elected) Psolar registry (sponsor Jansen Biotech), International Society for Investigative Dermatology, National The Agency for Healthcare Research and Quality, National

Hospital Affiliation

Dr. Gelfand is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Yeung H, Wan J, Van Voorhees AS, Callis Duffin K, Kreuger GG, Kalb RE, Weisman JD, Sperber BR, Brod BA, Bebo F, Schleicher SM, Shin DB, Troxel AB, and Gelfand JM.: "Patient reported reasons for the discontinuation of commonly used treatments for moderate-to-severe psoriasis." Journal of American Academy of Dermatology 68 : 64-72,2013.

Mehta NN, Torigian DA, Gelfand, JM, Saboury, B, and Alavi A: Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography (PET)/Computed Tomography (CT) Journal of Visualized Experiments 63 : e3777,2012.

Azfar AS, Seminara NM, Shin DB, Troxel AB, Margolis DJ, and Gelfand JM: Increased Risk of Diabetes and Likelihood of Receiving Diabetes Treatment in Patients with Psoriasis Archives of Dermatology 18 : 1 - 6,2012.

Gelfand JM, Wan J, Callis Duffin, K, Krueger GG, Kalb RE, Weisman JD, Sperber BR, Stierstorfer MB, Brod BA, Schleicher SM, Bebo BF, Troxel AB, Shin DB, Steinemann JM, Goldfarb J, Yeung H, and Van Voorhees AS: Comparative Effectiveness of Commonly Used Systemic Treatments or Phototherapy for Moderate to Severe Plaque Psoriasis in the Clinical Practice Setting Archives of Dermatology 148 (4): 487-94,2012.

Langan SM, Seminara, NM, Shin, DB, Troxel A, Kimmel SE, Mehta NN, Margolis DJ, and Gelfand JM: Prevalence of metabolic syndrome in patients with psoriasis: A population-based study in the United Kingdom Journal of Investigative Dermatology Advance Online Publication : 2011.

Mehta N, Yu YD, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, Baer A, Antigua J, Van Voorhees AS, Torigian DA, Alavi A, and Gelfand JM: Systemic and Vascular Inflammation in Patients with Moderate to Severe Psoriasis as measured by [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT): A Pilot Study Archives of Dermatology 147 (9): 1031-1039,2011.

Dommasch, ED, Abuabara, K, Shin, DB, Nguyen, J, Troxel, AB, and Gelfand JM.: The Risk of Infection and Malignancy with Tumor Necrosis Factor Antagonists in Adult Patients with Psoriatic Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Journal of the American Academy of Dermatology 64 (6): 1035-1060,2011.

Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, and Gelfand JM: Patients with severe psoriasis are at increased risk of cardiovascular mortality: Cohort study using General Practice Research Database European Heart Journal 31 : 1000-06,2010.

Gelfand JM, Dommasch E, Shin DB, Azfar RS, Kurd SK, Wang X, and Troxel AB: The Risk of Stroke in Patients with Psoriasis Journal of Investigative Dermatology 129 : 2411-2418,2009.

Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, and Troxel AB: The risk of lymphoma in patients with psoriasis Journal of Investigative Dermatology 126 : 2194-2201,2006.

Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, and Rolstad T: Epidemiology of Psoriatic Arthritis in the United States Population Journal of the American Academy of Dermatology 53 : 573-7,2005.

Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, and Troxel AB: The risk of myocardial infarction in patients with psoriasis Journal of the American Medical Association 296 : 1735-1741,2006.

Academic Contact Info

Perelman Center for Advanced Medicine
7th Floor, South Tower
Suite 730

Philadelphia, PA 19104
Phone: (215) 614-0635
Patient appointments: 800-789-PENN (7366)

Related Links